Oncogenesis of Helicobacter pylori and Associated Colorectal Cancer

• Emhamed Ahmed Boras

  Libyan Academy of postgraduate Studies, Life Science Department, Tripoli/ Janzor

  Author

• Mohamad Alahmar

  Tripoli Ministry of Health, Tripoli Medical Center

  Author

• Sh-hoob El-ahmir

  Faculty of science, Botany Department, Gharyan University.

  Author

• Omro A. Aburas

  Higher Institute of Science and Medical Technology, Pharmacy Department, Tripoli/Abusalim.

  Author

• Noor Thamer Alsanawi

  Libyan Academy of postgraduate Studies, Life Science Department, Tripoli/ Janzor

  Author

Background and objective: Helicobacter pylori [H.pylori] infection is one of the most common chronic bacterial infections worldwide especially in the developing countries. This bacterium is the cause of many diseases such as MALT lymphoma, gastritis, peptic ulcers, and stomach cancer. According to recent reports, H.pylori infection may increase the risk of colorectal cancer. The current study aimed at investigating the association of H. pylori infection and the risk of colorectal cancer and adenomatous polyps. Methods: The current study was conducted on 52 patients with colon cancer as the case group and 200 subjects without pathological finding (i e, polyps, neoplasms, or inflammatory diseases) as the control group. Blood samples were collected from the patients in order to assess the presence of anti-H. pylori infection antibodies by the serum titer levels of anti-H. pylori IgG antibodies were measured using enzyme-linked immunosorbent assay (ELISA) with commercial kit by (Dia.Pro Diagnostic Bioprobes-Italy). Results: This study demonstrates distinct associations between H.pylori infection markers and CRC risk. While IgG seropositivity showed a significant 2.16-fold increased CRC risk (p = 0.019). Conclusion: This research finding IgG seropositivity may serve as a broader risk marker.

1. Emhamed Ahmed Boras, Libyan Academy of postgraduate Studies, Life Science Department, Tripoli/ Janzor

   Libyan Academy of postgraduate Studies, Life Science Department, Tripoli/ Janzor

Azevedo M, N. F., Oleastro, M., Azeredo, J., Figueiredo., (2021). Host glycans in bacterial adhesion. Nature Reviews Microbiology 19(5):325-337.

Boren T, Piddubnyi, A., Tkachenko, I., Rakhimova, L., Edlund, J. O., (2022). Molecular mechanisms of H. pylori attachment. Cell Host & Microbe 30(1):45-59.

Brenner H., Stock, C., & Hoffmeister, M., (2014). Colorectal cancer. Lancet, 383(9927):1490-1502. Seminal review of CRC risk factors.

Butt, J., Varga, M. G., Blot, W. J., Teras, L., Visvanathan, K., Le Marchand, L., & Epplein, M. (2019). Helicobacter pylori and colorectal cancer—a prospective population-based study. Gut, 68(5), 854-860.

Buttar, N. S., Wang, K. K., & Leontovich, O., (2017). Biomarkers of gastrointestinal inflammation. Gastroenterology, 152(5), 1045-1058.

Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., & Holt, R. A., (2012). Fusobacterium in colorectal carcinogenesis. Genome Research, 22(2):292-298.Landmark microbiome-CRC study.

Chen Y, Xiong, Q., Ma, J., Chen, S., Wu, H., Xu, H., & Hou, B., (2022). Metabolic inflammation in H. pylori infection. Nature Reviews Gastroenterology & Hepatology 19(5):323-337.

Epplein, M., Xiang, Y. B., Cai, Q., Peek, R. M., Li, H., Correa, P., & Zheng, W., (2013). Helicobacter pylori biomarkers and risk of colorectal oncogenesis. Cancer Epidemiology, Biomarkers & Prevention, 22 (11), 1964-1974.

Engin AB, Karahail B, Engin A, Karakaye AE., (2010) Oxidative stress, helicobacter pylori and OGG1 ser326Cys, XPC Lys939Gln and XPD Lys751 Gln polymorphisms in a Turkish population with colorectal carcinoma. Genet Test Mol Biomarkers.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. (2008) Estimates of worldwide burden of cancer in. Int J Cancer.

Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A., (2000) Helicobacter pylori: seropreva- lence and colorectal cancer. Med Assoc J.

Fujimori S, Kishida T, Kobayash, T., (2005) Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcino especially in women. J Gastroenterol.

Gutman M, Fidler IJ., (1995) Biology of human colon cancer metastasis. World J Surg.

Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC., (2001) Helicobacter pylori infection, gastrin, cyclooxy- genase-2 and apoptosis in colorectal cancer. Int J colorectal Dis.

Hooi, J. K. Y., Lai, W. Y., Ng, W. K., (2017). Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology, 153 (2), 420–429.

Ilver D, J Ogren, Inga-Maria Frick, D Kersulyte, E T Incecik, D E Berg, A Covacci., (2023). Blood group antigen recognition by H. pylori. Science Advances 9(15): eabq3251.

Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH., (2002). Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev.

Marshall, B. J., Windsor, H. M., & Kimura, K., (2012). H. pylori: its diseases and management. Textbook of Clinical Gastroenterology and Hepatology.Monajemmi AR., (2000) Cancer. Second ed. Tehran: Azadmhr Publication.

Negrini, R., Savio, A., Poiesi, C., Appelmelk, B. J., & Buffoli, F. (2017). Helicobacter pylori infection and autoimmune gastritis. Frontiers in Immunology, 8, 398.

Rawla, P., Sunkara, T., & Barsouk, A., (2019). Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol, 14 (2), 89-103.

Rickert RR, Auerbach O, Garfinkel L, Ham- mond EC, Frasca JM., (1979) Adenomatous lesions of the large bowel: an autopsy survey. Cancer.

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A., (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73 (1), 17-48.

Suerbaum, S., & Michetti, P., (2002). Helicobacter pylori infection. New England Journal of Medicine, 347(15), 1175-1186.

Suzuki, H., Marshall, B. J., & Asaka, M., (2022). Vascular dysfunction in Helicobacter pylori-associated diseases: Mechanisms and clinical implications. Circulation Research, 130(1), 78-92.

Wang, F., Meng, W., Wang, B., & Qiao, L., (2014). Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Letters, 345(2), 196-202.

Wu, Q., Yang, Z. P., Xu, P., Gao, L. C., & Fan, D. M., (2013). Association between Helicobacter pylori infection and the risk of colorectal neoplasia: A systematic review and meta-analysis. Colorectal Disease, 15 (7), e352-e364.

Wong, B. C., Lam, S. K., Wong, W. M., (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA, 291 (2), 187–194.

Zarmouh A, Almalti A, Alzedam A, Hamad M, Elmughrabi H, Alnajjar L, Elmugassabi M, Kashbour M, Elsaghayer W., (2022) Cancer incidence in the middle region of Libya: Data from the cancer epidemiology study in Misurata. Cancer Rep (Hoboken).

Zhou, X., Li, J., Zhang, Y., Chen, L., Liu, W., Wang, Y., Zhang, G., & Gong, Y. (2023). Hyperglycemia promotes bacterial persistence via inhibition of the antimicrobial peptide REG3γ in the gut. Science Translational Medicine, 15(682), Article eabn3251.

Zumkeller N, Brenner H, Chang-Claud J, Hoffmeister M, Nieters A, Routhenbacher D., (2007) Helicobacter pylori infection, interlukin-1 gen polymorphisms and the risk of colorectal can- cer: evidence from a case-control study in Ger- many. Eur J Cancer.

Zumkeller, N., Brenner, H., Zwahlen, M., & Rothenbacher, D., (2006). Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter, 11(2), 75–80.

• pdf

Copyright (c) 2025 Emhamed Ahmed Boras, Mohamad Alahmar, Sh-hoob El-ahmir, Omro A. Aburas, Noor Thamer Alsanawi (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.